News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,360 Results
Type
Article (15015)
Company Profile (281)
Press Release (265064)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (82301)
Career Advice (159)
Deals (13827)
Drug Delivery (35)
Drug Development (53746)
Employer Resources (33)
FDA (6228)
Job Trends (5341)
News (151620)
Policy (10986)
Tag
Academia (932)
Accelerated approval (3)
Adcomms (12)
Allergies (52)
Alliances (22219)
ALS (72)
Alzheimer's disease (859)
Antibody-drug conjugate (ADC) (101)
Approvals (6255)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (110)
Best Places to Work (4725)
BIOSECURE Act (6)
Biosimilars (44)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (21)
Breast cancer (155)
Cancer (1545)
Cardiovascular disease (119)
Career advice (139)
Career pathing (2)
CAR-T (121)
Cell therapy (344)
Cervical cancer (8)
Clinical research (43963)
Collaboration (549)
Compensation (259)
Complete response letters (15)
COVID-19 (1045)
CRISPR (42)
C-suite (167)
Cystic fibrosis (81)
Data (1585)
Denatured (11)
Depression (30)
Diabetes (143)
Diagnostics (1322)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (88)
Drug pricing (32)
Drug shortages (3)
Duchenne muscular dystrophy (91)
Earnings (31316)
Editorial (19)
Employer branding (4)
Employer resources (31)
Events (50702)
Executive appointments (471)
FDA (6984)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (508)
Gene editing (98)
Generative AI (10)
Gene therapy (262)
GLP-1 (376)
Government (1191)
Grass and pollen (2)
Guidances (22)
Healthcare (6875)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (94)
Indications (21)
Infectious disease (1110)
Inflammatory bowel disease (114)
Inflation Reduction Act (9)
Influenza (19)
Intellectual property (68)
Interviews (18)
IPO (7619)
IRA (14)
Job creations (915)
Job search strategy (133)
Kidney cancer (7)
Labor market (5)
Layoffs (216)
Leadership (3)
Legal (1475)
Liver cancer (43)
Lung cancer (216)
Lymphoma (113)
Machine learning (3)
Management (9)
Manufacturing (143)
MASH (55)
Medical device (2640)
Medtech (2641)
Mergers & acquisitions (6542)
Metabolic disorders (401)
Multiple sclerosis (56)
NASH (13)
Neurodegenerative disease (74)
Neuropsychiatric disorders (25)
Neuroscience (1285)
NextGen: Class of 2025 (2153)
Non-profit (899)
Now hiring (21)
Obesity (199)
Opinion (106)
Ovarian cancer (63)
Pain (44)
Pancreatic cancer (62)
Parkinson's disease (125)
Partnered (8)
Patents (134)
Patient recruitment (80)
Peanut (35)
People (26257)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (15286)
Phase II (20505)
Phase III (13145)
Pipeline (842)
Policy (50)
Postmarket research (888)
Preclinical (6294)
Press Release (30)
Prostate cancer (64)
Psychedelics (35)
Radiopharmaceuticals (214)
Rare diseases (310)
Real estate (1489)
Recruiting (12)
Regulatory (9468)
Reports (15)
Research institute (970)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (64)
Service/supplier (1)
Sickle cell disease (43)
Special edition (11)
Spinal muscular atrophy (125)
Sponsored (13)
Startups (2007)
State (1)
Stomach cancer (5)
Supply chain (26)
Tariffs (9)
The Weekly (36)
Vaccines (218)
Venture capitalists (32)
Weight loss (111)
Women's health (15)
Worklife (2)
Date
Today (98)
Last 7 days (531)
Last 30 days (1576)
Last 365 days (20231)
2025 (6500)
2024 (21253)
2023 (23225)
2022 (27886)
2021 (28886)
2020 (24508)
2019 (17050)
2018 (12430)
2017 (14721)
2016 (12645)
2015 (15324)
2014 (11032)
2013 (7936)
2012 (7892)
2011 (7947)
2010 (7714)
Location
Africa (154)
Alabama (42)
Alaska (2)
Arizona (54)
Arkansas (5)
Asia (18117)
Australia (3017)
California (3935)
Canada (1162)
China (366)
Colorado (150)
Connecticut (157)
Delaware (104)
Europe (39853)
Florida (499)
Georgia (118)
Idaho (16)
Illinois (240)
India (10)
Indiana (96)
Iowa (2)
Japan (78)
Kansas (64)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (493)
Massachusetts (3194)
Michigan (71)
Minnesota (146)
Mississippi (1)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (34)
New Hampshire (14)
New Jersey (1015)
New Mexico (12)
New York (1073)
North Carolina (564)
North Dakota (5)
Northern California (1733)
Ohio (113)
Oklahoma (9)
Oregon (21)
Pennsylvania (768)
Puerto Rico (6)
Rhode Island (19)
South America (220)
South Carolina (4)
Southern California (1518)
Tennessee (26)
Texas (471)
United States (13698)
Utah (55)
Virginia (98)
Washington D.C. (31)
Washington State (355)
Wisconsin (15)
280,360 Results for "jupiter orphan therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
April 24, 2025
·
8 min read
Press Releases
Jupiter Neurosciences and Aquanova AG Announce Strategic Collaboration to Develop Longevity and Healthspan Products
March 4, 2025
·
5 min read
Press Releases
Purespring Therapeutics granted European Medicines Agency (EMA) orphan drug designation for PS-002 for the treatment of patients with primary IgA nephropathy (IgAN)
April 28, 2025
·
4 min read
Press Releases
Bioxodes obtains Orphan Drug Designation for hemorrhagic stroke therapeutic candidate in US and Europe
March 5, 2025
·
4 min read
Press Releases
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT2100 for the Treatment of Cystic Fibrosis
March 26, 2025
·
3 min read
Press Releases
GRIN Therapeutics Receives FDA Orphan Drug Designation for Radiprodil for the Treatment of GRIN-Related Neurodevelopmental Disorder
March 17, 2025
·
5 min read
Press Releases
Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones
February 5, 2025
·
5 min read
Press Releases
AccurEdit Therapeutics’ LNP-based In Vivo Gene Editing Product ART001 Obtained Orphan Drug Designation from the FDA
March 26, 2025
·
1 min read
Press Releases
Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson’s Trial
January 30, 2025
·
4 min read
Press Releases
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
January 14, 2025
·
6 min read
1 of 28,036
Next
